Drugs / adenylosuccinic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07412821 | Mar 2026 → Dec 2027 expected | — | Cure ADSSL1 | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adenylosuccinic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07412821 ↗ |
| Route | Subcutaneous | “by sub-cutaneous infusion pump” NCT07412821 ↗ |